Improving cervical cancer screening among women in Uganda
A Hybrid Implementation-Effectiveness Trial of Game Changers for Cervical Cancer Prevention in Uganda
This study is all about helping women in Uganda get screened for cervical cancer by training those who have already been screened to share their experiences and encourage their friends and family to do the same, making it easier for everyone to understand the importance of screening and overcome any fears or misunderstandings.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rand Corporation NIH-funded |
| Lab location | 1 site (Santa Monica, United States) |
| Project ID | NIH-10901937 on NIH RePORTER |
What this research studies
This research focuses on increasing cervical cancer screening rates among women in Uganda, where the disease is a leading cause of cancer-related deaths. It utilizes a peer-led intervention called Game Changers for Cervical Cancer Prevention, which empowers women who have recently undergone screening to educate and encourage others in their social networks. The approach addresses barriers to screening by providing knowledge, dispelling myths, and reducing stigma associated with cervical cancer. The effectiveness of this intervention will be evaluated through a randomized controlled trial.
Who could benefit from this research
Good fit: Ideal candidates for this research are women in Uganda, particularly those who have not previously undergone cervical cancer screening.
Not a fit: Patients who have already been screened for cervical cancer or those living outside of Uganda may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase cervical cancer screening rates, leading to earlier detection and better outcomes for women in Uganda.
How similar studies have performed: Previous pilot studies have shown promising results in increasing screening rates through similar peer-led interventions, indicating potential for success in this larger trial.
Where this research is happening
Santa Monica, United States
- Rand Corporation — Santa Monica, United States (Active)
Researchers
- Principal investigator: Wagner, Glenn John — Rand Corporation
- Study coordinator: Wagner, Glenn John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.